Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 158,158 | 144,178 | 189,718 | 189,818 | 177,347 |
| Marketable Securities | 347,387 | 443,615 | 583,658 | 678,125 | 769,734 |
| Receivables | 135,943 | 141,288 | 110,455 | 96,645 | 78,801 |
| Inventories | 15,004 | 15,281 | 15,856 | 15,613 | 16,441 |
| TOTAL | $694,676 | $774,009 | $954,368 | $1,011,140 | $1,066,233 |
| Non-Current Assets | |||||
| PPE Net | 64,913 | 59,088 | 52,585 | 46,354 | 42,910 |
| Intangibles | 842,495 | 846,006 | 807,182 | 805,601 | 799,420 |
| Other Non-Current Assets | 201,973 | 120,488 | 123,921 | 144,230 | 150,106 |
| TOTAL | $1,109,381 | $1,025,582 | $983,688 | $996,185 | $992,436 |
| Total Assets | $1,804,057 | $1,799,591 | $1,938,056 | $2,007,325 | $2,058,669 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 223,930 | 219,664 | 208,831 | 202,009 | 44,335 |
| Accounts payable and accrued liabilities | 330,918 | 246,521 | 288,784 | 252,329 | 235,921 |
| Other current liabilities | 1,451 | 1,450 | 1,460 | 1,222 | 1,250 |
| TOTAL | $567,371 | $476,776 | $509,348 | $465,261 | $290,962 |
| Non-Current Liabilities | |||||
| Long Term Debt | 962,766 | 956,979 | 956,588 | 952,153 | 1,095,325 |
| Other Non-Current Liabilities | 300,353 | 300,632 | 313,519 | 328,199 | 319,017 |
| TOTAL | $1,418,904 | $1,413,396 | $1,427,270 | $1,437,138 | $1,571,130 |
| Total Liabilities | $1,986,275 | $1,890,172 | $1,936,618 | $1,902,399 | $1,862,092 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 71,541 | 71,338 | 71,362 | 70,698 | 70,605 |
| Common Shares | 71 | 71 | 71 | 70 | 70 |
| Retained earnings | -2,376,770 | -2,224,683 | -2,097,957 | -1,954,717 | -1,821,093 |
| Other shareholders' equity | 10,251 | -18,608 | -24,282 | -32,961 | -46,087 |
| TOTAL | $-182,218 | $-90,581 | $1,438 | $104,926 | $196,577 |
| Total Liabilities And Equity | $1,804,057 | $1,799,591 | $1,938,056 | $2,007,325 | $2,058,669 |